{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/343698544"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "After 2 months (or cycles) of therapy, participants will be evaluated in order to assess the response and toxicity of treatment, including a review of medical history, physical examination, blood tests, including PSA. If there is no evidence of progression or excessive toxicity, treatment will continue for 2 more months in the same manner." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "clinicaltrials.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/102284756"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/343698544"] } } }
